论文信息 - Does comparative-effectiveness research threaten personalized medicine?

Does comparative-effectiveness research threaten personalized medicine?

Concerns have been raised that comparative-effectiveness research (CER) will not take adequate account of individual patient differences and may impede the development and adoption of improvements in medical care. Drs. Alan Garber and Sean Tunis argue that CER offers a way to hasten the discovery of the best approaches to personalization.

S. Tunis | A. Garber | Alan M Garber | Sean R Tunis

[1] B. Horne,et al. Randomized Trial of Genotype-Guided Versus Standard Warfarin Dosing in Patients Initiating Oral Anticoagulation , 2007, Circulation.

[2] E. Nabel,et al. Pharmacogenomics--ready for prime time? , 2008, The New England journal of medicine.

[3] S. Pocock,et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials , 2009, The Lancet.

[4] Nancy R Cook,et al. Cardiovascular Disease Risk Prediction With and Without Knowledge of Genetic Variation at Chromosome 9p21.3 , 2009, Annals of Internal Medicine.

[5] N. Paynter,et al. Cardiovascular Disease Risk Prediction With and Without Knowledge of Genetic Variation at Chromosome 9 p 21 . 3 , 2008 .